Navigation Links
Boehringer Ingelheim Invests More Than $350 Million in 2011 U.S. Expansion Projects
Date:11/15/2011

RIDGEFIELD, Conn., Nov. 15, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities. Privately-held, family-owned Boehringer Ingelheim continues to grow by improving its state-of-the-art facilities and enhancing its research, development and manufacturing capabilities.

The latest investment is a 72,000 square-foot research and development facility at the company's U.S. headquarters in Ridgefield, Connecticut. When complete the $65 million facility will handle production of active pharmaceutical ingredients used in early development activities. Products developed here, if approved, move on to Boehringer Ingelheim's full-scale R&D facilities in Ohio and Virginia, as well as Germany and Italy.

"This new R&D facility will help generate life-saving drugs and improve the health of countless people. As new drug invention continues to be in short supply, I am pleased that Boehringer Ingelheim is expanding this critical work right here in Connecticut, helping to grow both jobs and healthcare," said U.S. Senator Richard Blumenthal (D-Conn.).

"The ground-breaking research that will take place at this facility will put successful medical ideas to work for millions of additional patients, all while creating jobs here in Connecticut," Congressman Jim Himes (D-Conn.) said. "Congratulations to Boehringer Ingelheim on this new chapter. I look forward to our continued work together."

Other investment announcements by Boehringer Ingelheim in 2011 include:

In August, the company announced its investment in a new drug safety assessment building in Ridgefield, Conn. The $42 million project is scheduled to be completed in 2013 and will provide space for non-clinical safety studies.

The company's U.S. animal health busi
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
2. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
3. Boehringer Ingelheim Broadens Its Breast Cancer Clinical Trial Program for the Investigational Compound Afatinib
4. Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
5. Boehringer Ingelheim and Ashokas Changemakers Launch "Making More Health" Competition
6. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
7. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
8. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
9. Positive Phase 2 Results Reported with Boehringer Ingelheims Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
10. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
11. Boehringer Ingelheim to Purchase Amgens Fremont (USA) Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 ... report "Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT ... - I-131, Alpha Emitters, Brachytherapy - Y-90), by ... 2020", published by MarketsandMarkets, this report studies the ... of 2015 to 2020. This market is expected ...
(Date:7/7/2015)... julio de 2015 Sequent Medical, una ... en el desarrollo de dispositivos innovadores para el ... que R. Michael Kleine se ha ... Kleine cuenta con más de 25 años de ... y la sanidad. Ha gestionado con éxito varias ...
(Date:7/7/2015)... 30, 2015 Research ... addition of the "The New Trends of ... their offering. The report, The New ... unique insights into the current development states and ... development outsourcing market. The report is designed to ...
Breaking Medicine Technology:Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 2New Trends in the 2015 Global Preclinical Development Outsourcing Market 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 5
... LAKE SUCCESS, N.Y., Sept. 7, 2011 As NFL coaches ... strength and conditioning programs, one team,s preparation will be gaining ... during the 2011 NFL season. Today, Polar USA and the ... has been designated the "Official Heart Rate Training System" of ...
... 7, 2011 Cyberonics, Inc. (NASDAQ: CYBX ), ... participate in the 2011 UBS Global Life Sciences Conference on ... Moore, Cyberonics, President and Chief Executive Officer, will speak to ... live audio webcast of the presentation can be accessed by ...
Cached Medicine Technology:Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 3
(Date:7/7/2015)... Irvine, CA (PRWEB) , ... July 07, 2015 ... ... outlined a report from Cambridge Consultants that discussed how innovation and technology ... The article outlined the need to address issues of accessibility and affordability, especially ...
(Date:7/7/2015)... ... ... Silverado today issues its first update on construction of a new memory care ... in Bellingham, Washington. Cordata Design Review Board approved design and landscape plans for the ... local community. , The new complex – located at the 4400 block of Cordata ...
(Date:7/7/2015)... , ... July 07, 2015 ... ... convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, ... program, surpassing their original 2015 fundraising goal by nearly $100,000, to help ...
(Date:7/7/2015)... ... July 07, 2015 , ... A June ... rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by the ... youthful than she has in some time and speculate that she might have ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters to ... is a state of the art building, located with easy access to New York ... said, "We are pleased to service our clients from such a premier location and ...
Breaking Medicine News(10 mins):Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 3Health News:New Silverado Memory Care Community Receives Unanimous Approval from Design Review Board 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3
... is also available in Chinese on EurekAlert! ... and pain some people experience while using in-ear headphones, hearing ... external sound -- have found not only what they believe ... separate papers and a presentation at the 130th Audio Engineering ...
... In a time of transition for rural African-American ... stay focused on their goals and avoid potential difficulties ... ongoing University of Georgia study., The study, published in ... Community Psychology, is part of a broader research ...
... routine medical exam, Charles Harris learned that he had incurable ... keep family and friends current on his progress, and found ... book Incurable, an account of a man,s struggle to live ... illness. An entrepreneur and investor by profession, Charles Harris ...
... -- Use of the illegal drug ecstasy is associated with ... U.S. researchers used functional MRI to compare the brain,s response ... had used ecstasy, though not within two weeks of the ... Ecstasy users with the highest lifetime exposure to the drug ...
... Japanese and U.S. scientists in the young field of epigenetics ... silenced and others are not. Because this effect can be ... and other diseases using this information. The NOVA ... In Your Genes." It is the study of changes in ...
... 2011 Each year during National Nurses Week, UC ... patient care, education and guidance, mentorship, and teamwork. ... care," said Karen Grimley, chief nursing officer at UC ... noted that the approximately 1,200 nurses there are caring ...
Cached Medicine News:Health News:Sound safety 2Health News:Sound safety 3Health News:Sound safety 4Health News:Sound safety 5Health News:Study finds youth-mentor relationships particularly helpful for those experiencing hardship 2Health News:Ecstasy Use May Make Brain Less Efficient 2Health News:Study gives clue as to how notes are played on the genetic piano 2
... Size: 4.0 x 80 mm. Storz ... line designed by Harvey A. Lincoff, ... cell sponge which is non-toxic and ... edges to minimize scleral intrusion. These ...
... 80 mm. Half oval. The original Scleral Sponge ... has been modified by Dr. Joseph Olk with ... closed cell sponge which is non-toxic and non-antigenic. ... scleral intrusion. These implants are packaged sterile and ...
For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 15.0 mm....
For use with E5381 600 Circling Band (40 style)....
Medicine Products: